A widely used clinical test for AKI is NEPHROCHECK (NC; Astute Medical), which detects urinary biomarkers tissue inhibitor of metalloproteinases and insulin-like growth-factor binding protein 7 to assess for risk of moderate or severe AKI.6 Here, IGFBP7 is linked to acute kidney injury.